INTRODUCTION
Sickle cell disease (SCD) is one of the commonest inherited disorders worldwide, affecting an estimated 300 000 newborns every year. 1 With improved general healthcare, the majority of patients with SCD in developed countries can expect to survive to adulthood. In adulthood, however, SCD can be associated with multiorgan damage, including pulmonary complications. Acute chest syndrome is the commonest cause of death in young adults, and pulmonary dysfunction is a major contributor to morbidity in aging adults with SCD. Lung function abnormalities are common in adults with SCD. [2] [3] [4] [5] [6] [7] Adults with SCD can suffer from parenchymal lung disease and pulmonary vascular disease or both; affected individuals can suffer premature death. Echocardiographic abnormalities consistent with raised pulmonary artery systolic pressure (PAP) suggestive of pulmonary hypertension occur in approximately 30% of adult SCD patients [8] [9] [10] and are associated with increased morbidity and mortality. 8 9 11 Right heart catheterisation studies, however, have demonstrated that only a proportion of SCD patients have pulmonary arterial hypertension (PH), that is, elevated pulmonary arterial vascular resistance, and it is the presence of PH that is associated with early death. 12 Nevertheless, elevated tricuspid valve regurgitant velocities demonstrated by echocardiography and thought to be suggestive of raised PAP are independently predictive of mortality. 8 13 We have previously demonstrated that the majority of a cohort of adult patients with SCD had pulmonary abnormalities on high-resolution CT (HRCT). 7 The HRCT findings significantly correlated with pulmonary function testing results; in particular, there were correlations between reductions in FVC and FEV 1 and the prominence of the central vessels on HRCT. Prominent central vessels were found on HRCT in eight of the nine patients
Key messages
What is the key question?
▸ Vascular abnormalities on high-resolution CT (HRCT) would be associated with echocardiographic changes and lung function abnormalities in patients with sickle cell disease (SCD) and with the decline in lung function seen in SCD patients.
What is the bottom line?
▸ We have demonstrated an association between small vessel pulmonary vascular dimensions on HRCT reflecting pulmonary vascular volume, lung function abnormalities and echocardiographic estimates of ventricular function and cardiac output in adults with SCD; in addition, the decline in lung function correlated with changes in vascular dimension.
Why read on?
▸ Alterations in pulmonary vascular volumes due to anaemia in SCD patients may be responsible for some of their lung function abnormalities and changes seen on HRCT and their decline in lung function.
with restrictive abnormalities. The prominent central vessels may reflect the raised pulmonary capillary blood volume as a result of chronic anaemia causing an increased cardiac output (CO) 14 and dilation of the pulmonary vessels. 15 We have demonstrated in SCD children that the increased pulmonary capillary blood volume contributes to their increased airways obstruction. 16 Hence, we hypothesised that the central vessel prominence would be associated with echocardiographic changes and lung function abnormalities. The aim of this study was to test that hypothesis by prospectively undertaking HRCT studies, lung function and echocardiographic assessments. A further aim of this study was to reassess the cohort examined 7 years ago 7 to determine whether any decline in lung function correlated with vascular changes evidenced by HRCT studies.
METHODS
Adults with SCD were assessed between 2009 and 2013. Subjects included in the previous study 7 had initially been assessed between 2003 and 2005. All participants gave written informed consent.
Lung function assessments FEV 1 , vital capacity (VC), forced expiratory flow between 25 and 75% of VC (FEF 25/27 ), total lung capacity (TLC), residual volume (RV) and mean respiratory system resistance (Rrs) were measured.
CT
CT patterns were quantified independently by two thoracic radiologists blinded to the clinical and functional data. The extent and severity of CT abnormalities were recorded in individual lobes, the lingula being considered a separate lobe for scoring purposes. Distal vessel dimensions, including both arteries and veins at the sub-subsegmental level, 17 were measured using the method of Matsuoka et al. 18 19 The total summated cross-sectional area for the vessels was then expressed as a percentage of the total lung area of the three selected slices using threshold values between −500 and −1024 HU (cross-sectional area (CSA)<5 mm%) (figure 1). The mean segmental artery/bronchus (A/B) ratio in at least three of four lobes was calculated. CT total lung volume (TLV CT ) was derived using a proprietary lung segmentation algorithm (figure 2). For the longitudinal analyses, initial and follow-up CT scans were compared.
Echocardiography
Two-dimensional and three-dimensional transthoracic echocardiography was performed according to the international guidelines. 20 Examinations were performed using digital acquisitions on a Phillips Sonos 7500 ultrasound system. Valvular 2 ). PAP (normal <25 mm Hg) was calculated as the sum of RVSP and right atrial systolic pressures. CO (normal range 4.0-8.0 L/s) and right-ventricular diastolic volumes (RVDV) (normal range 100-160 mL) were also measured. Right and left ventricular function were assessed by measurement of the tricuspid annular plane systolic excursion (TAPSE) (normal >1.5 cm) and the ratio of early diastolic LV inflow (E) to lateral mitral annulus velocity (e 0 ) measured by tissue Doppler (E/e 0 ) (normal <8). Technically acceptable TAPSE measurements were available in 32 patients and E/e 0 in 33 patients.
Statistical analysis
See online supplement.
RESULTS Subjects
Thirty-five patients with a median age of 43 (range 17-73) years were assessed. In total, 20 of the 35 patients (median age at initial assessment 38, range 17-66 years) had been assessed at a median of 6.6 (range 5.5-6.7) years previously.
Lung function test results
There was a wide variation in the lung function of the cohort (table 1) . In total, 28 of the 35 patients (80%) had lung function abnormalities: 8 (23%) had a restrictive abnormality, 6 (17%) an obstructive abnormality, 4 (11%) a mixed abnormality and 10 (29%) an isolated reduction in carbon monoxide diffusing capacity (DLCO). Six patients (17%) had a significant response to bronchodilator; three had an obstructive, one a mixed and one a restrictive abnormality, and one no lung function abnormality. Sixteen patients (46%) had elevated Rrs; six of whom otherwise had normal lung function.
HRCT abnormalities
A reticular pattern on HRCT was the most prevalent and extensive abnormality, seen in 26 patients (median 5 (range 0-17.5) %). Ground glass opacification was present in nine patients (median extent 0 (range 0-3)). Consolidation was seen in nine patients (median extent 0.4 (0-4.2)). Reduction in lobar volume was seen in 19 patients (median severity 1 (range 0-7)). Linear bands were seen in 23 patients (median 1 (range 0-6)) and subpleural curvilinear lines in 9 patients (median 0 (range 0-3)).
Subpleural consolidation (n=6), thickened interlobular septa (n=2), infarcts (n=7) and traction bronchiectasis (n=0) were present in a minority of patients and excluded from further analysis. The median pulmonary artery to ascending aorta ratio (PA/AA) was 0.90 (range 0. The segmental A/B ratio and CSA<5 mm% exhibited a strong degree of multicollinearity. Therefore, separate models were generated with segmental A/B ratio or CSA<5 mm% as predictors. On stepwise regression, the segmental A/B ratio was independently related to a reduced FEV 1 
Echocardiography results
The median TRV was 2.65 (range 1.19-3.60) (m/s), the median estimated PAP 33.5 (range 9.0-70.0) (mm Hg), the median CO 6.0 (range 3.3-9.1) (L/min) and the median RVDV 93.9 (range 36.7-182.6) (mL). The median TAPSE was 2.30 (1.00-3.95) (cm), and the median E/e 0 ratio was 7.60 (4.70-16.60). Significant correlations were observed between CO and the A/B ratio (r=0.41, p=0.0120) and the CSA<5 mm% (r=0.35, p=0.0440), but not with the estimated PAP. There was a correlation of CSA<5 mm% with E/e 0 (r=0.45, p=0.009). There was also a correlation of CSA<5 mm% with TAPSE (r=−0.38, p=0.035), but only one subject had an abnormal TAPSE result (<1.5) and thus we cannot comment on the relationship between HRCT indices of vascular dilatation and echo indices of RV dysfunction.
The segmental A/B ratio and the CSA<5 mm% were significantly correlated with the haemoglobin level (r=−0.50, p=0.0021; r=−0.42, p=0.0090, respectively) and the lactate dehydrogenase (LDH) level (r=0.33, p=0.0450; r=0.33, p=0.0492, respectively). The segmental A/B ratio was related to the bilirubin level (r=0.47, p=0.0037) and the CSA<5 mm% to the reticulocyte count (r=0.39, p=0.0167).
Longitudinal analysis
The lung function results of the 20 patients who were reassessed had declined significantly (table 4) . There were, however, no significant changes seen in the prevalence or extent/severity of lung parenchymal abnormalities on CT, but both the median segmental A/B ratio and CSA<5 mm% had increased significantly over the follow-up period (table 5). The percentage change from baseline in the A/B ratio correlated negatively with that in FEV 1 (r=0.330, p=0.0156) and carbon monoxide transfer coefficient, corrected for haemoglobin concentration (KCO) (r=−0.554, p=0.0139) and positively with that in RV (r=0.475, p=0.0342) and RV:TLC (r=−0.557, p=0.0107). The percentage change from baseline in CSA<5 mm% correlated negatively with that in FEV 1 (r=−0.330, p=0.0079) and VC (r=−0.487, p=0.0357) and positively with RV:TLC (r=0.557, p=0.0164). Logistic regression demonstrated that a higher CSA<5 mm% at baseline was predictive of a subsequent overall deterioration in HRCT appearance, that is, a gestalt change score of 1 (OR 2.62 (95% CI 1.14 to 6.01) per unit increase in CSA<5 mm%, p=0.023). Linear mixed model analysis demonstrated a significant association of baseline CSA<5 mm% with subsequent decline in TLC, with an increased decline of −1.84% (95% CI −3.31 to −0.37) per year for each unit increase in CSA<5 mm % at baseline, p=0.014. CSA<5 mm% was also predictive of a more rapid change in RV:TLC, with a change in slope of +4.93% (95% CI 0.88 to 8.99) per year per unit increase in CSA<5 mm% at baseline, p=0.017.
DISCUSSION
We have demonstrated that pulmonary vascular abnormalities on HRCT were significantly related to pulmonary function impairment in adults with SCD. The segmental A/B ratio and CSA<5 mm% were independently linked to reductions in FEV 1 , VC and FEF 25/75 and to increased respiratory system resistance and RV:TLC. In addition, small vessel size correlated with reduced oxygen saturation and haemoglobin concentration and increased LDH, bilirubin and reticulocyte levels. Those results suggest relationships between anaemia, haemolysis, hypoxia and pulmonary function abnormalities. We found a positive correlation between CSA<5 mm% (a measure of distal arteries and veins) and E/e 0 which is a marker of left atrial filling pressure that is elevated if there is LV diastolic dysfunction. A higher E/e 0 would result in some elevation of pulmonary venous pressure, and this result suggests a role for precapillary and postcapillary pulmonary vascular changes in SCD-related lung 3 who found a much lower incidence of airflow obstruction. The differences may be due to a number of factors. We used a recently reported ethnic-specific reference range for spirometry, 21 whereas Klings et al 3 used a Caucasian reference range with fixed correction factors to adjust for ethnicity. We classified abnormalities based on the lower limit of normal based on percentiles recommended by the American and European Thoracic Societies, 22 whereas Klings et al used a fixed percentage predicted value to define the lower limit of normal for all lung function indices, which does not take into account that the limits of the normal range vary with age, sex and ethnicity. Furthermore, the classification scheme in the Kling's study specified that in order to be classified as obstructive or mixed, the DLCO had to be normal, which precluded the possibility that impaired gas transfer coexisted with airway abnormalities.
Restrictive lung function defects, that is, a reduced TLC and RV, were not associated with the extent of ground glass opacification or a reticular pattern and showed only a modest association with linear bands, suggesting interstitial fibrosis may not be the predominant mechanism for loss of lung volume in patients with SCD. Indeed, most CT markers of pulmonary fibrosis showed no association with reductions in VC, FEV 1 , FEF 25/75 , RV:TLC SpO 2 , Rrs(0) or Rrs (1) . The extent of a reticular pattern was associated with a reduction in respiratory system resistance; we speculate that this might be due to the tractional effects of areas of fibrosis on adjacent bronchi. Subpleural curvilinear bands were noted in 26% of patients; this is an unusual CT sign, formerly believed to be pathognomonic of early asbestosis. 23 Subpleural curvilinear bands have subsequently been described in association with micro-atelectasis in patients with atrial septal defect 24 or respiratory muscle weakness 25 and as reversible sign caused by interstitial oedema resulting from pulmonary congestion. 26 Observations in subjects without lung disease and undergoing lymphography have led to the suggestion that the sign may represent an engorged subpleural lymphatic network. 27 Given the presence of a high-output state in SCD, and the correlation of subpleural curvilinear lines with markers of small-vessel dilatation observed in our cohort, it is tempting to speculate that this pattern may be related to interstitial oedema and/or increased lymphatic drainage.
We highlight a decline in lung function over a mean of 6.6 years in adults with SCD. A significant decrease was observed in VC, FEV1, FEF 25/75 , FEV1:VC and KCOc with a significant increase in RV:TLC. There were no significant changes in the results of the CT assessments other than in vascular dimension assessments, where both the A/B ratio and CSA<5 mm% significantly increased. Those results suggest changes in pulmonary vascular dimensions may be responsible for the decline in lung function. Furthermore, a greater baseline CSA<5 mm% was predictive of a more rapid progression of both obstructive (increasing RV:TLC) and restrictive (decreasing TLC) lung disease and an increased likelihood of a deterioration in parenchymal disease, as evidenced on HRCT examination. Our results emphasise the phenotypic heterogeneity of SCD lung disease. The changes in vascular morphology related to obstructive defects and the likelihood of deteriorating interstitial lung disease, suggesting that there may be a shared mechanism involving small pulmonary vessels. Field et al 28 demonstrated that bone marrow-derived fibrocytes may be mobilised into the circulation and subsequently extravasate into the lungs of SCD mice. There they function as mesenchymal progenitor cells for the production of extracellular matrix and contribute to the development of fibrosis. Elevated levels of circulating fibroctyes have been observed in humans with SCD. 28 We, therefore, speculate that pulmonary vascular engorgement and distension may potentiate extravasation of circulating fibrocytes.
This study has strengths, but some limitations too. A strength of this study was the use of two different quantitative methods for assessing pulmonary vascular morphology, the segmental A/B ratio and CSA<5 mm%, which yielded similar results. We used ethnic-specific references for spirometric indices, but the static lung volume results were related to reference ranges derived from Caucasian subjects with a fixed correction factor to account for ethnicity. All the study population were African or Caribbean, thus correlations within the cohort and comparisons between results at baseline and follow-up were valid. A limitation is that we did not have right heart catheterisation data for pulmonary artery pressures and resistance, but all the patients underwent the same echocardiographic protocol. Studies have demonstrated a minority of patients with elevated TRV have elevated pulmonary artery pressure. In a recent study, only 8 of 26 patients with elevated TRV at echocardiography had elevated pulmonary artery pressure confirmed by right heart catherisation 29 and similar findings were reported in a larger study with 10.4% of 243 patients with elevated TRV having pulmonary hypertension. 30 It should be noted, however, that a TRV of >2.5 m/s (corresponding to an estimated mPAP greater than or equal to approximately 2 SDs above normal) does not meet the criteria for right-heart catheter-defined pulmonary arterial hypertension (mPAP >25 mm Hg), which is 3 SDs above normal. The latter corresponds to a TRV of approximately 3.0 m/s, which occurs in only about one-third of patients. Different HRCT protocols were used in our earlier study, 7 and in this study, however, care was taken to ensure that all the images used for comparisons were from anatomically comparable sections. In addition, scoring was undertaken by observers who were blinded to the results of lung function and echocardiography results. The consistent relationship between CSA<5 mm%, A/B ratio and lung function test results suggests the different protocols did not adversely influence our results. We have shown that, if TLV CT is measured, volumetric HRCT scans are able to capture both restrictive and obstructive functional abnormalities, providing an alternative method to assess global pulmonary impairment in patients with SCD.
In conclusion, we have demonstrated an association between small-vessel pulmonary vascular dimensions on HRCT reflecting pulmonary vascular volume, lung function abnormalities and echocardiographic estimates of CO and ventricular function in adults with SCD. Our results suggest that abnormalities in pulmonary vascular volumes may explain some of the lung function abnormalities and the decline in lung function seen in adults with SCD.
